High prevalence of pathogenic germline variants in patients with oncogene-driven non-small cell lung cancer.

被引：0

作者：

Mezquita, Laura ^{[1
,2
]}

Iurchenko, Andrei ^{[3
]}

Benitez, Jose Carlos ^{[4
]}

Baz, Maria ^{[4
]}

Nikolaev, Sergey ^{[3
]}

Planchard, David ^{[4
]}

Blanc-Durand, Felix ^{[4
]}

Aldea, Mihaela ^{[4
]}

Martin-Romano, Patricia ^{[5
]}

Loriot, Yohann

Nicotra, Claudio ^{[5
]}

Ngocamus, Maud ^{[5
]}

Scoazec, Jean-Yves ^{[6
]}

Michiels, Stefan ^{[5
,7
]}

Postel-Vinay, Sophie

Viot, Julien

Friboulet, Luc ^{[3
]}

Italiano, Antoine ^{[5
]}

Andre, Fabrice ^{[8
]}

Massard, Christophe ^{[5
]}

Soria, Jean-Charles

Rouleau, Etienne ^{[9
]}

Gautheret, Daniel ^{[10
]}

Besse, Benjamin ^{[11
]}

机构：

[1] Gustave Roussy, Canc Med Dept, Villejuif, France

[2] Hosp Clin Barcelona, Med Oncol Dept, Translat Genom Solid Tumors, IDIBAPS, Barcelona, Spain

[3] Univ Paris Saclay, Gustave Roussy, Bioinformat Unit, INSERM U981, Villejuif, France

[4] Gustave Roussy, Canc Med Dept, Villejuif, France

[5] Gustave Roussy, Early Drug Dev Dept, Villejuif, France

[6] Gustave Roussy, Pathol Dept, Villejuif, France

[7] Univ Paris Saclay, Biostat & Epidemiol Dept, Labeled Ligue Canc, Gustave Roussy Canc Campus,Oncostat U1018 INSERM, Villejuif, France

[8] Paris Saclay Univ, Canc Med Dept, Gustave Roussy, Villejuif, France

[9] Gustave Roussy, Dept Med Biol & Pathol, Villejuif, France

[10] Univ Paris Saclay, Gustave Roussy, IHU PRISM, I2BC,CNRS,CEA, Villejuif, France

[11] Paris Saclay Univ, Canc Med Dept, Gustave Roussy, Villejuif, France

来源：

CANCER RESEARCH | 2021年 / 81卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

448

引用

页数：2

共 50 条

[1] Prevalence of incidental pathogenic germline variants detected in cfDNA in patients with oncogene-driven non-small cell lung cancer.
Mezquita, Laura
Bucheit, Leslie A.
Carlos Laguna, Juan
Pastor, Belen
Teixido, Cristina
Gorria, Teresa
Albarran-Artahona, Victor
Garcia De Herreros, Marta
Reyes, Roxana
Reguart, Noemi
Vinolas, Nuria
Arcocha, Ainara
Puig-Butille, Joan Anton
Drusbosky, Leylah
Faull, Iris
Castro, Elena
Patel, Jyoti D.
Prat, Aleix
Besse, Benjamin
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[2] Treatment of oncogene-driven non-small cell lung cancer
Kastelijn, Elisabeth A.
de Langen, Adrianus J.
Peters, Bas J. M.
[J]. CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (03) : 300 - 307
[3] Role of Immunotherapy for Oncogene-Driven Non-Small Cell Lung Cancer
Miura, Yosuke
Sunaga, Noriaki
[J]. CANCERS, 2018, 10 (08)
[4] Brain metastases in oncogene-driven non-small cell lung cancer
Nishino, Makoto
Soejima, Kenzo
Mitsudomi, Tetsuya
[J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S298 - S307
[5] Treatment Options for Patients with Brain Metastases in Oncogene-Driven Non-Small Cell Lung Cancer
Garitaonaindia, Y.
Martinez, M.
Traseira, C.
Calvo, V.
Franco, F.
Collazo, A.
Menchen, B.
Sanchez, A.
Nunez-Garcia, B.
Aguado, R.
Visedo, G.
Morito, A.
Blanco Clemente, M.
Provencio, M.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S663 - S665
[6] Efficacy of ICIs on patients with oncogene-driven non-small cell lung cancer: a retrospective study
Guo, Xiaojin
Du, He
Li, Jiayu
Yang, Menghang
Xiong, Anweng
Zhang, Haiping
Wu, Fengying
[J]. CANCER DRUG RESISTANCE, 2022, 5 (01) : 15 - 24
[7] Prevalence of pathogenic germline variants in a cohort of patients with early onset non-small cell lung cancer (EOLUNG).
Jove, Maria
Gausachs, Mireia
Bosch-Barrera, Joaquim
Carcereny, Enric
Teule, Alex
Mosteiro, Miguel
Pineda, Marta
Tornero, Eva
Hijazo-Pechero, Sara
Ruffinelli, Jose Carlos
Hernandez, Alejandro I.
Fina, Claudia
Sais, Elia
Brunet, Joan
Domenech, Marta
Saigi, Maria
Moran, Teresa
Lazaro, Conxi
Nadal, Ernest
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[8] Targeting glucose metabolism and EGFR signaling in oncogene-driven non-small cell lung cancer
De Rosa, V.
Iommelli, F.
Monti, M.
Terlizzi, C.
Del Vecchio, S.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S264 - S264
[9] When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?
Mhanna, Laurent
Guibert, Nicolas
Milia, Julie
Mazieres, Julien
[J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (07)
[10] When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?
Laurent Mhanna
Nicolas Guibert
Julie Milia
Julien Mazieres
[J]. Current Treatment Options in Oncology, 2019, 20

← 1 2 3 4 5 →